Technology News and Research

RSS

AvMed to optimize Member Services call center operation with Panviva SupportPoint

AvMed Health Plans announced today that it has chosen Panviva SupportPoint, a world-wide leader in Business Process Guidance (BPG) systems, to optimize its Member Services call center operation and drive even higher levels of member satisfaction.

10 Dec 2010

Harvard Bioscience files two major patents in regenerative medicine

Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.

From Harvard Bioscience 10 Dec 2010

FDA grants Neoprobe Type B pre-IND meeting for RIGS technology BLA

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.

10 Dec 2010

Prometheus, UCLA collaborate to identify biological markers of mucosal healing in IBD

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and The Regents of the University of California, Los Angeles campus, today announced the execution of an exclusive research agreement that will focus on the identification of biological markers of mucosal healing in patients with Inflammatory Bowel Disease (IBD). The research will be led by Dr. Jonathan Braun, Chair of the Department of Pathology and Laboratory Medicine and a professor of molecular and medical pharmacology, UCLA David Geffen School of Medicine.

10 Dec 2010

Fibrin microthreads support mesenchymal stem cell growth

A research team at Worcester Polytechnic Institute has demonstrated the feasibility of a novel technology that a surgeon could use to deliver stem cells to targeted areas of the body to repair diseased or damaged tissue, including cardiac muscle damaged by a heart attack. The technique involves bundling biopolymer microthreads into biological sutures and seeding the sutures with stem cells. The team has shown that the adult bone-marrow-derived stem cells will multiply while attached to the threads and retain their ability to differentiate and grow into other cell types.

10 Dec 2010

Horizon Discovery licenses new human isogenic cell models from Case Western Reserve

With the goal of developing new, more effective and personalized cancer treatments, Horizon Discovery, based in Cambridge, England, has secured from Case Western Reserve University exclusive rights to a panel of new human isogenic cell models developed by the laboratory of Zhenghe Wang, assistant professor of genetics at the university's School of Medicine.

10 Dec 2010

Celulas Genetica to submit international patent application for Rutherford Procedure

Emerging Healthcare Solutions, Inc. announced today that its newly acquired biotechnology division Celulas Genetica will submit an international patent application for the Rutherford Procedure, a revolutionary new stem-cell treatment for liver disease.

10 Dec 2010

Caliper to acquire CRi for $20.0 million

Caliper Life Sciences, Inc., a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held Cambridge Research & Instrumentation, Inc. (CRi) for approximately $20.0 million, including net debt. CRi's patented preclinical and tissue-based multiplexed analysis systems will expand Caliper's life sciences tools portfolio, particularly as it bridges into clinical research, pathology and clinical market applications.

10 Dec 2010

Presidential commission pushes feds to 'facilitate' more health IT

A report by a presidential advisory panel urges the federal government to be more aggressive in facilitating the adoption of universal standards for sharing electronic health information and maintaining patient privacy.

10 Dec 2010

Horizon Discovery secures exclusive rights to human isogenic cell models

With the goal of developing new, more effective and personalized cancer treatments, Horizon Discovery, based in Cambridge, England, has secured from Case Western Reserve University exclusive rights to a panel of new human isogenic cell models developed by the laboratory of Zhenghe John Wang, assistant professor of genetics at the university's School of Medicine.

10 Dec 2010

Haitian cholera pathogen closely related to 'El Tor O1' variant from South Asia

Scientists from Pacific Biosciences of California, Inc. and Harvard Medical School have successfully employed single molecule, real-time (SMRT™) DNA sequencing technology to rapidly characterize the pathogen responsible for the recent deadly cholera epidemic in Haiti. Published online Thursday in the New England Journal of Medicine, the results provide the first whole genome sequence analysis and most detailed genetic profile to date of the Haitian Vibrio cholerae outbreak strain.

10 Dec 2010

TeleHealth Services announces extended partnership with Central Baptist Hospital

TeleHealth Services, the nation's leading provider of healthcare-grade televisions and interactive patient education solutions, today announced an extended partnership with Central Baptist Hospital. The 383-bed hospital, an early adopter to on-demand education, implemented TIGR as their interactive patient education and entertainment solution as a part of their "meaningful use" project, and the further utilization of advanced technologies to increase the quality of healthcare at the facility.

10 Dec 2010

Biovex announces OncoVEXGM-CSF Phase 3 study for head and neck cancer

BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced today that a Phase 3 pivotal study with OncoVEXGM-CSF for the first line treatment of patients with locally advanced squamous cell carcinoma of the head & neck has commenced.

10 Dec 2010

Tobacco-cessation expert receives 2011 ASPO Joseph W. Cullen Memorial Award tobacco research

Behavioral scientist and tobacco-cessation expert, Alexander V. Prokhorov, M.D., Ph.D., at The University of Texas MD Anderson Cancer Center is the recipient of the 2011 American Society of Preventive Oncology (ASPO) Joseph W. Cullen Memorial Award for Excellence in Tobacco Research.

10 Dec 2010

Scientists to develop ultra-rapid sexually transmitted infection detection system for clinics

Scientists from the University of Southampton have secured funding to develop an ultra-rapid sexually transmitted infection (STI) detection system for clinics that can detect STIs in under 15 minutes.

9 Dec 2010

Research looks at early exposure to mobile phone risk

There has been plenty of speculation that mobile phones are not good for pregnant mums but a new study sheds light on the actual connection. It finds that pregnant women who regularly use mobile phones may be more likely to have children with behavioral problems, particularly if their children start using mobile phones in their first seven years. American researchers said that the risk of behavioral problems rose by 30% if such exposure was present. Those exposed before birth and in early childhood were at 50% higher risk than those who were not exposed they said.

9 Dec 2010

Ingenuity Systems and CLC bio collaborate to provide interoperability between software solutions

Today Ingenuity Systems and CLC bio announced that they're collaborating to provide interoperability between their software solutions. The aim of the partnership is to provide researchers with the ability to easily exchange data between CLC bio's enterprise and desktop solutions and Ingenuity's pathway analysis software (IPA®), in order to perform both array and next-generation sequencing data and knowledge analyses.

9 Dec 2010

Hamilton Thorne launches new Stiletto laser for regenerative medicine and stem cell research markets

Hamilton Thorne Ltd., a leading provider of advanced laser systems for the regenerative medicine and stem cell research markets, today announced the launch of its new Stiletto™ laser system. The Stiletto™ laser system has broad applications for research with a variety of cells, allowing the Company to enter new and exciting research markets, including developmental and advanced cell biology.

9 Dec 2010

BDSI initiates dosing in BEMA Buprenorphine Phase 3 clinical program for chronic pain

BioDelivery Sciences International, Inc. today announced the enrollment and dosing of the first patient in its Phase 3 clinical program evaluating the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain.

9 Dec 2010

Nacalai to distribute Techulon's Glycofect Transfection Reagent platform products in Japan

Techulon Inc., an early stage life sciences company has signed an agreement with Nacalai USA, Inc. and its parent company Nacalai Tesque, Inc. for distribution of its Glycofect Transfection Reagent platform products in Japan. Glycofect is a polymeric transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used by government, university and corporate laboratories around the world for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.

9 Dec 2010

Technology News and Research

AvMed to optimize Member Services call center operation with Panviva SupportPoint

Harvard Bioscience files two major patents in regenerative medicine

FDA grants Neoprobe Type B pre-IND meeting for RIGS technology BLA

Prometheus, UCLA collaborate to identify biological markers of mucosal healing in IBD

Fibrin microthreads support mesenchymal stem cell growth

Horizon Discovery licenses new human isogenic cell models from Case Western Reserve

Celulas Genetica to submit international patent application for Rutherford Procedure

Caliper to acquire CRi for $20.0 million

Presidential commission pushes feds to 'facilitate' more health IT

Horizon Discovery secures exclusive rights to human isogenic cell models

Haitian cholera pathogen closely related to 'El Tor O1' variant from South Asia

TeleHealth Services announces extended partnership with Central Baptist Hospital

Biovex announces OncoVEXGM-CSF Phase 3 study for head and neck cancer

Tobacco-cessation expert receives 2011 ASPO Joseph W. Cullen Memorial Award tobacco research

Scientists to develop ultra-rapid sexually transmitted infection detection system for clinics

Research looks at early exposure to mobile phone risk

Ingenuity Systems and CLC bio collaborate to provide interoperability between software solutions

Hamilton Thorne launches new Stiletto laser for regenerative medicine and stem cell research markets

BDSI initiates dosing in BEMA Buprenorphine Phase 3 clinical program for chronic pain

Nacalai to distribute Techulon's Glycofect Transfection Reagent platform products in Japan

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News